MRS 1845
CAS: 544478-19-5
Ref. 3D-UWA47819
| 5mg | 462.00 € | ||
| 10mg | 657.00 € | ||
| 25mg | 1,105.00 € | ||
| 50mg | 1,768.00 € | ||
| 100mg | 2,829.00 € |
Product Information
- 3-Pyridinecarboxylic acid, 4-[3-(3-dioxaziridinyl)phenyl]-1,4-dihydro-5-(3-hydroxy-1-oxopropyl)-2,6-dimethyl-1-(2-propyn-1-yl)-, methyl ester
- Methyl 4-[3-(dioxaziridin-3-yl)phenyl]-5-(3-hydroxypropanoyl)-2,6-dimethyl-1-(prop-2-yn-1-yl)-1,4-dihydropyridine-3-carboxylate
MRS 1845 is a cytostatic drug that inhibits the growth of cancer cells by inhibiting mitochondrial membrane potential, which leads to an increase in intracellular calcium levels and the activation of apoptosis. MRS 1845 has been shown to inhibit the growth of cancer cells in vitro and in vivo. This drug also has clinical relevance for treatment of chronic myeloid leukemia (CML) and breast cancer. MRS 1845 inhibits the production of protein kinase C, which is an effector protein involved in cell proliferation.
Chemical properties
Technical inquiry about: 3D-UWA47819 MRS 1845
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
